dc.relation.reference | 1. Flores AM, Zohman LR. Rehabilitation of the cardiac patient. In. DeLisa JA, Gans BM eds., Rehabilitation Medicine, Principles and Practice, 2nd ed., Philadelphia: JB Lippincott Co., 1993: 934-51.
2. Irwin S. Philosophy and structure of a cardiac rehabilitation program. In. Irwin S, Tecklin JS eds., Cardiopulmonary Physical Therapy. 2nd ed., St. Louis: CV Mosby Co., 1990: 3-6.
3. Burnett CN. Principles of aerobic exercise. In. Kisner C, Colby LA eds., Therapeutic Exercise, Foundations and Techniques. 2nd ed., St. Louis: CV Mosby Co., 1990:637-45.
4. Saltin B. Response to exercise after bed rest and after training. Circulation 1968; 38(Suppl VII): 5.
5. Leon AS. Scientific evidence of value of cardiac rehabilitation services with emphasis on patients following MI - section I. Exercise conditioning component. J Cardiopulm Rehabil 1990; 10:79-87.
6. Oldridge NB, Guyatt GH, Fischer ME, et al. Cardiac rehabilitation after myocardial infarciton: combined experience of randomized clinical trials. JAMA 1988; 260: 945-50.
7. O’Connor GT, Buring JE, Yusurf S, et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 1989; 80: 234-.44.
8. Engblom E, Korpilahti K, Hamalainen H, et al. Quality of life and return to work 5 years after coronary artery bypass surgery, long-term results of cardiac rehabilitation. J Cardiopulm Rehabil 1997; 17: 29-36.
9. Engblom E, Ronnemaa T, Hamalainen H, et al. Coronary heart disease risk factors before and after bypass surgery: results of a controlled trial on multifactorial rehabilitation. Eur Heart J 1992; 13: 232-7.
10. Hedback B, Perk J, Wodlin P. Long-term reduction of cardiac mortality after myocardial infarction: 10-year results of a comprehensive rehabilitation program. Eur Heart J 1993; 14: 831-5.
11. Nishikawa E, Tomiyama H, Inagaki M, et al. Safety and effectiveness of exercise training in patients with silent myocardial ischemia, J Cardiol 1996; 28: 321-7.
12. Haskell WL. The efficiacy and safety of exercise programs in cardiac rehabilitation. Med Sci Sports Exerc 1994; 26: 815-23.
13. Van Camp SP, Peterson RA. Cardiovascular complications of outpatient cardiac rehabilitation programs. JAMA 1986; 256: 1160-3.
14. Haskell WL, Alderman EL, Fair JM, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Standford Coronary Risk Intervention Project (SCRIP). Circulation 1994; 89: 975-90.
15. Benari E, Rothbaum MD, Linnemeir TJ. Benefits of a monitored rehabilitation program versus physician care after emergency percutaneous transluminal coronary angioplasty: follow-up of risk factors and rate of restenosis. J Cardiopulm Rehabil 1989; 7: 281-5.
16. Balady GJ,Fletcher BJ, Froelicher ES, et al. Cardiac rehabilitation programs, a statement for healthcare professionals from the American Heart Association. Circulation 1994; 90: 1602-10.
17. Wenger NK, Balady GJ, Cohn LH, et al. Cardiac rehabilitation services following PTCA in valvular surgery: guidelines for use /American College of Cardiology. Cardiology 1990; 19: 4-5.
18. Belardinelli R, Paolini I, Cianci G, et al. Exercise training intervention after coronary angioplasty: the ETICA trial. J Am Coll Cardiol 2001; 37: 1891-900.
19. Subcommittee on Percutaneous Transluminal Coronary Angioplasty. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures. Circulation 1988; 78: 486-502.
20. Myler RK. Coronary and peripheral angioplasty: Hospital perspective. In. Topol EJ, editor. Textbook of Interventional Cardiology. 2nd ed. Philadelphia: WB Saunders Company; 1994.
21. Feinleib M, Havlik RJ, Gillum RF, et al: Coronary heart disease and related procedures: National hospital discharge survey data. Circulation 1992; 85: 849-60.
22. Maier W, Meier B. Interventional cardiology in perspective: impact on cardiac rehabilitation. Eur Heart J 1998; 19 (Suppl O): O24-8.
23. 行政院衛生署編。民國八十九年衛生統計動向。初版。台北市:衛生署;2002年:陸-22。
24. Tsai MW, Chie WC. The growth of interventional cardiac revascularization in Taiwan: Impact on cardiac rehabilitation. Formosan J Phys Ther 2004; 29: 31-9.
25. Parisi AF, Folland ED, Hartigan P, et al. A comparison of angioplasty with medical therapy in the treatment single-vessel coronary artery disease. N Engl J Med 1992; 326: 10-6.
26. Berger E, Williams DO, Reinert S, et al. Sustained efficacy of percutaneous transluminal coronary angioplasty. Am Heart J 1986; 111: 233-6.
27. Sherman DL, Ryan TJ. Coronary angioplasty versus Bypass grafting, cost-benefit considerations. Med Clin North Am 1995; 79: 1085-95.
28. Gruentzig AR, King SB, Schlumpf M, et al. Long-term follow-up after percutaneous transluminal coronary angioplasty. N Engl J Med 1987; 316: 1127-32.
29. Serruys PW, Luijten HE, Beatt KJ, et al. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. Circulation 1988; 77: 361-71.
30. Hirshfeld JW Jr, Schwartz JS, Jugo R, et al. Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. J Am Coll Cardiol 1991; 18: 647-56.
31. Beatt KJ, Serruys PW, Luijten HE, et al. Restenosis after coronary angioplasty: the paradox of increased lumen diameter and restenosis. J Am Coll Cardiol 1992; 19: 258-66.
32. Currier JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target ? J Am Coll Cardiol 1995; 25: 516-0.
33. Liu MW, Roubin GS, King SB. Restenosis after coronary angioplasty. Potential biologic determinants and role of initimal hyperplasis. Circulation 1989; 79: 1374-87.
34. Morimoto S, Sekiguchi M, Endo M, et al. Mechanism of luminal enlargement in PTCA and restenosis: a histopathological study of necropsied coronary arteries collected from various centers in Japan. Japan Circulation J 1987; 51: 1101-15.
35. Geoge G, Ge J, Erbel R. Role of intravascular ultrasound in the evaluation of mechanisms of coronary interventions and restenosis. Am J Cardiol 1998; 81: 91G-5G.
36. Corcos T, David PR, Val PG, et al. Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1985; 109: 926-31.
37. Allen JK, Xu X: Coronary revascularization in women. Crit Care Nurs Clin North Am 1997; 9: 497-509.
38. Kishi K, Hiasa Y, Tanaka H, et al. The important of serum lipid level for restenosis following initial successful percutaneous transluminal coronary angioplasty in patients with unstable angina. J Cardiol 1996; 28: 79-84.
39. Gurlek A, Dagalp Z, Oral D, et al. Restenosis after transluminal coronary angioplasty: a risk factor analysis. J Cardiovas Risk 1995; 2: 51-5.
40. Yamamoto H, Imazu M, Yamazu M, et al. Risk factors for restenosis after percutaneous transluminal coronary angioplasty: role of lipoprotein (a). Am Heart J 1995; 130: 1168-73.
41. Geol PK, Shahi M, Agarwal AK, et al. Platelet aggregability and occurrence of restenosis following coronary angioplasty. Int J Cardiol 1997; 60: 227-31.
42. Bresee SJ, Jacobs AK, Garber GR, et al. Prior restenosis predicts restenosis after coronary angioplasty of a new significant narrowing. Am J Cardiol 1991; 68: 1158-62.
43. Kotamaki M, Laustiola K, Syvanne M, et al. Influence of continued smoking and some biological risk factors on restenosis after percutaneous transluminal coronary angioplasty. J Intern Med 1996; 240: 293-301.
44. Weintraub WS, Kosinski AS, Brown CL III, et al. Can restenosis after coronary angioplasty be predictor from clinical variables? J Am Coll Cardiol 1993; 21: 6-14.
45. Honan MB, Bengtson JR, Pryor DB, et al. Exercise treadmill testing is a poor predictor of anatomic restenosis after angioplasty for acute myocardial infarction. Circulation 1989; 80: 1585-94.
46. Bengtson JR, Mark DB, Honan MB, et al. Detection of restenosis after elective percutaneous transluminal coronary angioplasty using exercise treadmill test. Am J Cardiol 1990; 65: 28-34.
47. Wijns W, Serruys PW, Simoons ML, et al. Predictive value of early maximal exercise test and thallium scintigraphy after successful percutaneous transluminal coronary angioplasty. Br Heart J 1985; 53: 194-200.
48. Jorgensen B, Simonsen S, Endresen K, et al. Physiologic response to gain and loss in coronary minimal luminal diameter in patients treated with coronary angioplasty: prediction of restenosis on the basis of exercise capacity. Am Heart J 2000; 139: 482-90.
49. Hayano JH, Yamada A, Mukai S, et al. Severity of coronary atherosclerosis correlates with the respiratory component of heart rate variability. Am Heart J 1991; 121: 1070-9.
50. Osterhues HH, Koochs M, Hombach V. Time-dependent changes of heart rate variability after percutaneous transluminal angioplasty. Am Heart J 1998; 135: 755-61.
51. Birand A, Kudaiberdieva G, Batyraliev TA, et al. Effects of trimetazidine on heart rate variability and left ventricular systolic performance in patients with coronary artery disease after percutaneous transluminal angioplasty. Angiology 1997; 48: 413-22.
52. Tseng CD, Wang TL, Lin JL, et al. The cause-effect relationship of sympathovagal activity and the outcome of percutaneous transluminal coronary angioplasty. Japan Heart J 1996; 37: 455-62.
53. Lanza GA, Pedrotti P, Pasceri V, et al. Autonomic changes associated with spontaneous coronary spasm in patients with variant angina. J Am Coll Cardiol 1996; 28: 1249-56.
54. Sebrechts CP, Klein JL, Ahnve S, et al. Myocardial perfusion changes following 1 year of exercise training assessed by thallium-201 circumferential count profiles. Am Heart J 1986; 112: 1217-26.
55. Froelicher V, Jensen D, Atwood JE, et al. Cardiac rehabilitation: evidence for improvement in myocardial perfusion and function. Arch Phys Med Rehabil 1980; 61: 517-22.
56. Froelicher V, Jensen D, Sullivan M. A randomized trial of the effects of exercise training after coronary artery bypass surgery. Arch Intern Med 1985; 145: 689-92.
57. Hung J, Gordon EP, Houston N, et al. Changes in rest and exercise myocardial perfusion and left ventricular function 3 to 26 weeks after clinically uncomplicated acute myocardial infarction: effects of exercise training. Am J Cardiol 1984; 54: 943-50.
58. Kubo H, Yano K, Hirai H, et al. Preventive effect of exercise training on recurrent stenosis after percutaneous transluminal coronary angioplasty. Japan Circulation J 1992; 56: 413-21.
59. Kubo H, Yano K, Hasegawa N, et al. Effects of exercise training on restoration of residual myocardial ischemia after percutaneous transluminal coronary angioplasty. J Cardiol 1992; 22: 375-81.
60. Lan C, Chen SY, Chiu SF, et al. Poor functional recovery may indicate restenosis in patients after coronary angioplasty. Arch Phys Med Rehabil 2003; 84: 1023-7.
61. Wang J, Wolin MS, Hintze TH. Chronic exercise enhances endothelium-mediated dilation of epicardial coronary artery in conscious dogs. Circ Res 1993; 73: 829-38.
62. Charo S, Gokce N, Vita JA. Endothelial dysfunction and coronary risk reduction. J Cardiopulm Rehabil 1998; 18: 60-7.
63. Leitch JW, Newling RP, Basta M, et al. Randomized trial of a hospital-based exercise training program after acute myocardial infarction: cardiac autonomic effects. J Am Coll Cardiol 1997; 29: 1263-8.
64. Gregoire J, Tuck S, Yamamoto Y, Hughson RL. Heart rate variability at rest and exercise: influence of age, gender, and physical training. Canad J Appl Physiol 1996; 21: 455-70.
65. Levy WC, Cerqueira MD, Harp GD, et al. Effect of endurance exercise training on heart rate variability at rest in healthy young and older men. Am J Cardiol 1998; 82: 1236-41.
66. Bryniarski L, Kawecka-Jaszcz K, Bacior B, et al. Effect of exercise rehabilitation on heart rate variability in hypertensives after myocardial infarction. J Hypertension 1997; 15: 1739-43.
67. Malfatto G, Facchini M, Bragato R, et al. Short and long term effects of exercise training on the tonic autonomic modulation of heart rate variability after myocardial infarction. Eur Heart J 1996; 17: 532-8.
68. Leon AS, Certo C, Comoss P, et al. Scientific evidence of the value of cardiac rehabilitation services with emphasis on patients following myocardial infarction. J Cardiopulm Rehabil 1990; 10: 79-87.
69. Thomas RJ, Houston Miller N, Lamendola C, et al. National survey on gender differences in cardiac rehabilitation programs. J Cardiopulm Rehabil 1996; 16: 402-12.
70. Bunker S, McBurney H, Cox H, et al. Identifying participation rates at outpatient cardiac rehabilitation programs in Victoria, Australia. J Cardiopulm Rehabil 1999; 19: 334-8.
71. Ades PA, Meacham CP, Handy MA, et al. The cardiac rehabilitation program of the university of Vermont Medical Center. J Cardiopulm Rehabil 1986; 6: 265-77.
72. Tooth LR, McKenna KT, Maas F. Prediction of functional and psychological status after percutaneous transluminal coronary angioplasty. Heart Lung 1999; 28: 276-83.
73. Echteld MA, van Elderen T, van der Kamp L. How goal disturbance, coping and chest pain relate to quality of life: a study among patients waiting for PTCA. Qual Lif Res 2001; 10: 487-501.
74. Bliley AV, Ferrans GE. Psychologic aspects of cardiovascular care, quality of life after coronary angioplasty. Heart Lung 1993; 22: 193-9.
75. Wenger NK, Froelicher ES, Smith LK, et al. Cardiac Rehabilitation, clinical practice guideline No. 17. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research and the National Heart, Lungm and Blood Institute; 1995 [AHCPR Publication No. 96-0672]
76. Oldridge N, Guyatt G, Jones N, et al. Effects on quality of life with comprehensive rehabilitation after acute myocardial infarction. Am J Cardiol 1991; 67:1084-9.
77. Carlsson R. Serum cholesterol, lifestyle, working capacity and quality of life in patients with coronary artery disease, experiences from a hospital-based secondary prevention program. Scand Cardiovasc J 1998; 32: 1-20.
78. Contractor A, English R, Salmon R, et al. Clinical effectiveness of a community-based cardiovascular risk reduction program (intervent USA) in lower risk patients with coronary artery disease. AACVPR abstracts, J Cardiopulm Rehabil 2000; 20: 294.
79. Lavie CJ, Milani RV. Factors predicting improvements in lipid values following cardiac rehabilitation and exercise training. Arch Intern Med 1993; 153: 982-8.
80. Clausen JP. Heart rate and arterial blood pressure during exercise in patients with angina pectoris: effects of training and of nitroglycerin. Circulation 1976; 43: 436-41.
81. Irwin S. Abnormal exercise physiology, In. Irwin S, Tecklin JS, eds. Cardiopulmonary Physical Therapy. 2nd ed., St. Louis: CV Mosby Co., 1990: 99-112.
82. Coats AJ, Adamopoulos S, Meyer TE, et al. Effects of physical training in chronic heart failure. Lancet 1990; 335:63-6.
83. Meyer TR, Casadei B, Coats AJ, et al. Angiotensin-converting enzyme inhibition and physical training in heart failure. J Intern Med 1991; 230: 407-13.
84. Todd IC, Ballatyne D. Effect of exercise training on the total ischaemic burden: an assessment by 24 hour ambulatory electrocardiographic monitoring. Br Heart J 1992; 68: 560-6.
85. Jugdutt BI, Michorowski BL, Kappagoda CT. Exercise training after anterior Q wave myocardial infarction: importance of regional left ventricular function and topography. J Am Coll Cardiol 1988; 12: 362-72.
86. Kramsch DM, Aspen AJ, Abramowitz BM. Reduction of coronary atherosclerosis by moderate conditioning exercise in monkeys on a diet. N Engl J Med 1981; 305: 1483-8.
87. Ferguson RJ, Petticlerc R, Choquette G, et al. Effect of physical training on treadmill exercise capacity, collateral circulation and progression of coronary disease. Am. J Cardiol1974; 34: 764-9.
88. Conner JF, LaCamera R, Jr., Swanick EJ, et al. Effects of exercise on coronary collateralization - angiographic studies of six patients in a supervised exercise program. Med Sci Sports Exerc 1976; 8: 145-51.
89. Myers J, Ahnve S, Froelicher V, et al. A randomized trail of the effects of 1 year of exercise training on computer-measured ST segment displacement in patients with coronary artery disease. J Am Coll Cardiol 1984; 4: 1094-102.
90. Wood PD, Stefanick ML, Williams PT, Haskell WL: The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med 1991; 325: 461-6.
91. Despres JP, Lamarche B. Low-intensity endurance exercise training, plasma lipoproteins and the risk of coronary heart disease. J Intern Med 1994; 236: 7-22.
92. Lavie CJ, Milani RV. Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients. Am J Cardiol 1997; 79: 397-401.
93. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990; 336: 129-33.
94. Schuler G, Hambrech R, Schlierf G, et al. Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet. J Am Coll Cardiol 1992; 19: 34-42.
95. Schuler G, Hambrech R, Schlierf G, et al. Regular physical exercise and low fat diet: effects on progression of coronary artery disease. Circulation 1992; 86: 1-11.
96. Huttunen JK, Lansimies E, Voutilainen E, et al. Effect of moderate physical exercise on serum lipoproteins. Circulation 1979; 60: 1220-9.
97. Bittner V, Oberman A. Efficacy studies in coronary rehabilitation. Cardiol Clin 1993; 11: 333-47.
98. Juneau K, Rogers F, DeSantos V, et al. Effective ness of self-monitored, home-based, moderate intensity exercise training in middle-aged men and women. Am J Cardiol 1987; 60: 66-70.
99. Weltman A, Matter S, Stamford BA. Caloric restriction and/or mild exercise effects on serum lipids and body composition. Am J Clin Nutr 1980; 33: 1002-9.
100. Wood PD, Haskell WL, Blair SN, et al. Increased exercise level and plasma lipoprotein concentrations: A one-year, randomized, controlled study in sedentary middle-aged men. Metabolism 1983; 32: 31-9.
101. Verges BL, Patois-Verges B, Cohen M, Casillas JM. Comprehensive cardiac rehabilitation improves the control of dyslipidemia in secondary prevention. J Cardiopulm Rehabil 1998; 18: 408-15.
102. Goldberg L, Elliot D. The use of exercise to improve lipid and lipoprotein levels, In. Goldberg L, Elliot DL, eds. Exercise for prevention and treatment of illness. Philadelphia: FA Davis Company, 1994: 189-210.
103. Arroll B, Beaglehole R. Does physical activity lower blood pressure: a critical review of the clinical trials. J Clin Epidemiol 1992; 45: 439-47.
104. Kelley G, McClellan P. Antihypertensive effects of aerobic exercise. A brief meta-analytic review of randomized controlled trials. Am J Hypertens 1994; 7: 115-9.
105. Hedback B, Perk J, Engvall J. Predictive factors for return to work after coronary artery bypass grafting: the role of cardiac rehabilitation. Int J Rehabil Res 1992; 15: 148-53.
106. Hedback BE, Perk J, Engvall J, et al. Cardiac rehabilitation after coronary artery bypass grafting: effects on exercise performance and risk factors. Arch Phys Med Rehabil 1990; 71: 1069-73.
107. Hamalainen H, Luurila OJ, Kallio V, et al. Long-term reduction in sudden deaths after a multifactorial intervention programme in patients with myocardial infarction: 10-year results of a controlled investigation. Eur Heart J 1989; 10: 55-62.
108. Kallio V, Hamalainen H, Hakkila J, et al. Reduction in suddeen deaths by multifactorial intervention program after acute myocardial infarction. Lancet 1979; 2: 1091-4.
109. Leon AS. Patients with diabetes mellitus. In. Franklin BA, Gordon S, Timmis GC, eds: Exercise in modern medicine. Baltimore: Willliam & Wilkins, 1989: 118-45.
110. Campaigne BN. Exercise in the management of diabetes mellitus. In. Goldberg L, Elliot DL eds. Exercise for prevention and treatment of illness. Philadelphia: FA Davis Company, 1994: 173-88.
111. Helmrich SP, et al. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 1991; 325: 147-52.
112. LeBlanc J. Exercise training and energy expenditure, In: Bray GA, et al, eds. Diet and Obesity. Tokyo: Japan Sci. Soc. Press. 1988: 181-90.
113. Calles-Escandon, Horton ES. The thermogenic role of exercise in the treatment of morbid obesity: a critical evaluation. Am J Clin Nutr 1992; 55: 533S-7S.
114. Lampman RM, Schteingart DE. Moderate and extreme obesity, In. Franklin BA, Gordon S, Timmis GC, eds. Exercise in modern medicine. Baltimore: Willliam & Wilkins, 1989: 156-74.
115. Elliot DL, Goldberg L. Exercise and obesity. In. Goldberg L, Elliot DL, eds. Exercise for prevention and treatment of illness. Philadelphia: FA Davis Company, 1994: 211-27.
116. Pearson TA, LaCava J, Weil HFC. Epidemiology of thrombotic-hemostatic factors and their associations with cardiovascular disease. Am J Clin Nutr 1997; 65(suppl): 1764S-.82S.
117. Szymanski LM, Pate RR. Fibrinolytic response to moderate intensity exercise, comparison of physically active and inactive men. Arteriocler Thromb 1994; 14: 1746-.50.
118. Schleifer SJ, Macari-Hinson MM, Coyle DA, et al. The nature and course of depression following myocardial infarction. Arch Intern Med 1989; 149: 1785-9.
119. Appels A, Mulder P. Fatigue and heart disease, The association between 'vital exhaustion' and past, present and future coronary heart disease. J Psychosom Res 1989; 33: 727-38.
120. Appels A. Mental precursors of myocardial infarction. Br J Psychi 1990; 156: 465-71.
121. Kop WJ, Appels AP, Mendes de Leon CF, et al. Vital exhaustion predicts new cardiac events after successful coronary angioplasty. Psychosom Med 1994; 56: 281-7.
122. Milani RV, Lavie CJ, Cassidy MM. Effects of cardiac rehabilitation and exercise training programs on depression in patients after major coronary events. Am Heart J 1996; 132: 726-32.
123. Ahern DK, Gorkin L, Anderson JL, et al. Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol 1990; 66: 59-62.
124. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993; 270: 1819-25.
125. Taylor CB, Houston-Miller N, Ahn DK, et al. The effects of exercise training programs on psychosocial improvement in uncomplicated postmyocardial infarction patients. J Psychosom Res 1986; 30:581-7.
126. Sonstroem RJ, Morgan WP. Exercise and self-esteem: rationale and model. Med Sci Sports Exerc 1989; 21:329-37.
127. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989; 27(suppl): S217-32.
128. Renwick R, Friefeld S. Quality of life and rehabilitation. In. Quality in Health Promotion and Rehabilitation. 1996: 26-36.
129. Milani RV, Lavie CJ. Behavioral differences and effects of cardiac rehabilitation in diabetic patients following cardiac events. Am J Med 1996; 100: 517-23.
130. Engebretson TO, Clark MM, Niaura RS, et al. Quality of life and anxiety in a phase II cardiac rehabilitation program. Med Sci Sports Exerc 1999; 31: 216-23.
131. Cohen RA, Moser DJ, Clark MM, et al. Neurocognitive functioning and improvement in quality of life following participation in cardiac rehabilitation. Am J Cardiol 1999; 83:1374-8.
132. Lukkarinen H. Quality of life in coronary artery disease. Nurs Res 1998; 47: 337-43.
133. Cornell CE, Raczynski JM, Oberman A. Quality of life after coronary revascularization procedures. In. Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials, 2nd ed., Philadelphia: Lippincott-Raven Publishers, 1996: 865-91.
134. Shaw LW. Effects of a prescribed supervised exercise program on mortality and cardiovascular morbidity in patients after a myocardial infarction. Am. J. Cardiol 1981; 48: 39-45.
135. Rechnitzer PA, Cunningham DA, Andrew GM, et al. Exercise-Heart Collaborative Study: relation of exercise to the recurrence rate of myocardial infarction in men. Am J Cardiol 1983; 51: 65-9.
136. Shephard RJ. The value of exercise in ischemic heart disease, a cumulative analysis. J. Cardiopulm Rehabil. 1983; 3: 294-8.
137. May GS, Eberlein KA, Furberg CD, et al. Secondary prevention after myocardial infarction: a view of long-term trials. Prog. Cardiovasc. Dis. 1983; 34: 331-52.
138. Yusuf S, Collins R, Peto R, et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J 1985; 6: 556-85.
139. Lombardi F, Verrier RL, Lown B, et al. Relationship between sympathetic neural activity, coronary dynamics, and vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion. Am Heart J 1983; 105: 958-65.
140. Zipes DP. Influence of myocardial ischemia and infarction on autonomic innervation of heart. Circulation 1990; 82: 1095-105.
141. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability standards of measurement, physiological interpretation, and clinical use. Circulation 1996; 93: 1043-65.
142. Hayano J, Sakakibara Y, Yamada A, et al. Accuracy of assessment of cardiac vagal tone by heart rate variability in normal subjects. Am J Cardiol 1991; 67: 199-204.
143. Pagani M, Lombardi F, Guzzetti S, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in amn and conscious dog. Circ Res 1986; 59: 178-93.
144. Koizumi K, Terui N, Kollai M. Effects of cardiac vagal and sympathetic nerve activity on heart rate in rhythmic fluctuations. J Auton Nerv Syst 1985; 12: 251-9.
145. Yongue BG, McCabe PM, Porges SW, et al. The effects of pharmacologic manipulations that influence vagal control of the heart on heart period. Heart-period variability and respiration in rats. Psychophysiology 1982; 19: 426-32.
146. Cerutti S, Bianchi AM, Mainardi LT. Spectral analysis of the heart rate variability signal. In. Malik M, Camm AJ, eds. Heart rate variability. New York: Futura Publishing Company, Inc. 1995: 63-74.
147. Polanczyk CA, Rohde LE, Moraes RS, et al. Sympathetic nervous system representation in time and frequency domain indices of heart rate variability. Eur J Appl Physiol 1998; 79:69-73.
148. Kuo CD, Chen GY. Comparison of three recumbent positions on vagal and sympathetic modulation using spectral heart rate variability in patients with coronary artery disease. Am J Cardiol 1998; 81: 392-6.
149. Kleiger RE, Bigger JT, Bosner MS, et al. Stability over time of variables measuring heart period variability in normal subjects. Am J Cardiol 1991; 68: 626-30.
150. Goldsmith RL, Bigger JT Jr., Steinman RC, et al. Comparison of 24-hour parasympathetic activity in endurance-trained and untrained young men. J Am Coll Cardiol 1992; 20: 552-8.
151. Kuo TBJ, Lin T, Yang CCH, et al. Effect of aging on gender differences in neural control of heart rate. Am J Physiol Heart Circ Physiol 1999; 277: H2233-9.
152. Lombardi F, Sandrone G, Pernpruner S, et al. Heart rate variability as an index of sympatheovagal interaction after acute myocardial infarction. Am J Cardiol 1987; 60: 1239-45.
153. Airaksinen KEJ, Ikaheimo MJ, Huikuri HV, et al. Responses of heart rate variability to coronary occlusion during coronary angioplasty. Am J Cardiol 1993; 72: 1026-30.
154. Bigger JT, Fleiss JL, Steinman RC, et al. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992; 85: 164-71.
155. Hayano J, Sakakibara Y, Yamada M, et al. Decreased magnitude of heart rate spectral components in coronary artery disease: its relation to angiographic severity. Circulation 1990; 81: 1217-24.
156. Myers GA, Martin GJ, Magid NM, et al. Power spectral analysis of heart rate variability in sudden cardiac death: comparison to other methods. IEEE Trans Biomed Eng 1986; BME-33: 1149-56.
157. Vaishnav S, Stevenson R, Marchant B, et al. Relation between heart rate variability early after acute myocardial infarction and long-term mortality. Am J Cardiol 1994; 73: 653-7.
158. Schwartz PJ, Vanoli E, Stramba Badiale M, et al. Autonomic mechanisms and sudden death: New insights fro analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 1988; 78: 969-79.
159. Vanoli E, De Ferrari GM, Stramba-Badiale M, et al. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 1991; 68: 1471-81.
160. Minisi AJ, Thames MD. Effects of chronic myocardial infarction on vagal cardiopulmonary baroreflex. Circ Res 1989; 65: 396-403.
161. Saul JP, Arai Y, Berger RD, et al. Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. Am J Cardiol 1988; 61: 1292-9.
162. Kanadasi M, Kudaiberdieva G, Birand A. Effect of the final coronary arterial diameter after coronary angioplasty on heart rate variability responses. Ann Noninvasive Electrocardiol 2002; 7:106-13.
163. Billman GE, Schwartz PJ, Stone HL. The effects of daily exercise on the suspectibility to sudden cardiac death. Circulation 1984; 69: 1182-9.
164. La Rovere MT, Specchia G, Mortara A, et al. Baroreflex sensitivity, clinical correlates and cardiovascular mortality among patients with a first myocardial infarction. Circulation 1988; 78: 816-24.
165. Malfatto G, Facchini M, Sala L, et al. Effects of cardiac rehabilitation and beta-blocker therapy on heart rate variability after first acute myocardial infarction. Am J Cardiol 1998; 81: 834-40.
166. Fujimoto S, Uemura S, Tomoda Y, et al. Effects of physical training on autonomic nerve activity in patients with acute myocardial infarction. J Cardiol 1997; 29: 85-93.
167. Brenner IK, Thomas S, Shephard RJ. Spectrum analysis of heart rate variability during heat exposure and repeated exercise. Eur J Appl Physiol Occup Physiol 1997; 76:145-56.
168. Bryniarski L, Kawecka-Jaszcz K, Bacior B, et al. Effect of exercise rehabilitation on heart rate variability in hypertensives after myocardial infarction. J Hypertension 1997; 15: 1739-43.
169. Somers VK, Conway J, Johnston J, et al. Effects of endurance training on baroreflex sensitivity and blood pressure in borderline hypertension. Lancet 1991; 337: 1363-8.
170. Kautzner J. Reproducibility of heart rate variability measurement. In. Malik M, Camm AJ eds. Heart rate variability. New York: Futura Publishing Company, Inc. 1995:165-71.
171. American College of Sports Medicine. Guidelines for exercise testing and prescription. 6th ed., Philadelphia: Lea & Febiger, 2000: 91-113, 206-14..
172. Friedman LM, Furbeg CD, DeMets DL. Foundmentals of clinical trials. 3rd ed., Mosby-Year Book, Inc., 1996: 61-77, 94-129, 156-67, 185-201, 204-20.
173.
174. Portney LG, Watkins MP. Foundations of clinical research, applications to practice, 2nd ed., Prentice-Hall, Inc. 2000: 442-51.
175. Wasserman K, Hansen JE, Sue DY, Whipp BJ. Principles of exercise testing and interpretation. Philadelphia: Lea & Febiger, 1987: 58-71.
176. New England Medical Center Hospital. IQOLA SF-36 Taiwan Standard Version 1.0. Boston: The Health Institute, New England Medical Center, 1996.
177. Tsai MW, Chie WC. Reliability and Validity of a Chinese Version of Seattle Angina Questionnaire. Formosan J Med 2002; 6; 495-504.
178. Chie WC, Chen CF, Lee WC et al. Age-period-cohort analysis of breast cancer mortality. J Formos Med Assoc 1999; 98: 254-60.
179. Fuh JL, Wang SJ, Lu SR, et al. Psychometric evaluation of a Chinese (Taiwanese) Version of the SF-36 Health Survey amongst middle-aged women from a rural community. Qual Lif Res 2000; 9: 675-83.
180. Chiu HC, Chern JY, Shi HY, et al. Physical functioning and health-related quality of life: before and after total hip replacement. Kaohsiung J Med Sci 2000; 16: 285-92.
181. Spertus JA, Winder JA, Dewhurst TA, et al. Development and evaluation of the Seatle Angina Questionnaire: a new functional status measure for coronary arter disease. J Am Coll Cardiol 1995; 25: 333-41.
182. Krumholz HM, McHorney CA, Clark L, et al. Changes in health after elective percutaneous coronary revascularization, a comparison of generic and specific measures. Med Care 1996; 34: 754-9.
183. Spertus JA, Winder JA, Dewhurst TA, et al. Monitoring the quality of life in patients with coronary artery disease. Am J Cardiol 1994; 74:1240-4.
184. Höfer S, Benzer W, Schüßler G, et al. Health-related quality of life in patients with coronary artery disease treated for angina: validity and reliability of German translations of two specific questionnaires. Qual Lif Res 2003; 12: 199-212.
185. Dougherty CM, Dewhurst T, Nichol P, Spertus J. Comparison of three quality of life instruments in stable angina pectoris: Seattle Angina Questionnaire, Short Form Health Survey (SF-36), and Quality of Life Index-Cardiac Version III. J Clin Epidemiol 1998; 51: 569-75.
186. Kuo TBJ, Chan SHH. Continuous, on-line, real-time spectral analysis of arterial blood pressure using a personal computer. Am J Physiol Heart Circ Physiol 1993; 264: H2208-13.
187. Kuo TBJ, Yang CCH. Sexual dimorphism in the complexity of cardiac pacemaker activity. Am J Physiol Heart Circ Physiol 2002; 283: H1695-702.
188. Liu CC, Kuo TBJ, Lin T, Yang CCH. Effects of estrogen on gender-related autonomic differences in humans. Am J Physiol Heart Circ Physiol 2003; 283: H2188-93.
189. Yang TF, Chan RC, Kao CL, et al. Power spectrum analysis of heart rate variability for cerebral palsy patients. Am J Phys Med Rehabil 2002; 81: 350-4.
190. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, division of Nutrition and Physical Activity. Promoting physical activity: a guide for community action. Champaign: Human Kinetics Publishers; 1999:15-37.
191. Perini R, Fisher N, Veicsteinas A, et al.. Aerobic training and cardiovascular responses at rest and during exercise in older men and women. Med Sci Sports Exerc 2002; 34:700-8.
192. Fardy PS, Yanowitz FG. Cardiac rehabilitation, adult fitness, and exercise testing. 3rd ed. Baltimore: Williams & Wilkins; 1995: 33-51, 166-83.
193. New York Heart Association. Diseases of the heart and blood vessels: nomenclature and criteria for diagnoses. Boston: Little Brown and Company, 1964.
194. Gordon NF. Hypertension. In. Durstine JL, Moore GE, eds. ACSM’s exercise management for persons with chronic diseases and disabilities. 2nd ed., Champaign: Human Kinetics. 2003: 76-80.
195. Hornsby WG, Albright AL. Diabetes. In. Durstine JL, Moore GE, eds. ACSM’s exercise management for persons with chronic diseases and disabilities. 2nd ed., Champaign: Human Kinetics. 2003: 133-141.
196. Williams SG, Cooke GA, Wright DJ, et al. Disparate results of ACE inhibitor dosage on exercise capacity in heart failure: a reappraisal of vasodilator therapy and study design. Intern J of Cardiol 2001; 77:239-45.
197. Klug EQ, Joffe BI, Panz VR, et al.. Perindopril and physiologic responses to exercise. J Cardiovas Pharmacol 1994; 23:864-8.
198. Cornell CE, Raczynski JM, Oberman A. Quality of life after coronary revascularization procedures. In. Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia: Lippincott-Raven Publishers. 1996:.865-91.
199. Echteld MA, van Elderen T, van der Kamp L. How goal disturbance, coping and chest pain relate to quality of life: a study among patients waiting for PTCA. Qual Lif Res 2001; 10: 487-501.
200. Bliley AV, Ferrans GE. Psychologic aspects of cardiovascular care, quality of life after coronary angioplasty. Heart Lung 1993; 22: 193-9.
201. Ware JE. SF-36 Health Survey. Manual and Interpretation Guide. Boston: The Health Institute, New England Medical Center. 1993:10:1-38.
202. Demirel S, Akkaya V, Oflaz H, et al. Heart rate variability after coronary artery bypass graft surgery: a prospective 3-year follow-up study. Ann Noninvasive Electrocardiol 2002; 7: 247-50.
203. Melanson EL, Freedson. The effect of endurance on resting heart rate variability in sedentary adult males. Eur J Appl Physiol 2001; 85: 442-9.
204. Ramaekers D, Ector H, Aubert AE, et al. Heart rate variability and heart rate in healthy volunteers. Is the female autonomic nervous system cardioprotective? Eur Heart J 1998; 19: 1334-41.
205. Hainsworth R. The control and physiological importance of heart rate. In. Malik M, Camm AJ, eds. Heart rate variability. New York: Futura Publishing Company, Inc. 1995: 3-19.
206. Brum PC, Da Silva GJJ, Moreira ED, et al. Exercise training increases baroreceptor gain sensitivity in normal and hypertensive rats. Hypertension 2000; 36: 1018-22.
207. Iellamo F, Legramante JM, Massaro M, et al. Effects of a residential exercise training on baroreflex sensitivity and heart rate variability in patients with coronary artery disease, a randomized controlled study. Circulation 2000; 102: 2588-92.
208. Kingwell BA, Arnold PJ, Jennings GL, et al. Spontaneous running increases aortic compliance in Wistar-Kyoto rats. Circ Res 1997; 35: 132-7.
209. Cameron JD, Dart AM. Exercise training increases total systemic arterial compliance in humans. Am J Physiol 1994; 266: H693-701.
210. Kingwell BA, Cameron JD, Gillies KJ, et al. Arterial compliance may influence baroreflex function in athletes and hypertensives. Am J Physiol 1995; 268: H411-8.
211. Grassi G, Seravalle G, Calhoun DA, et al. Physical training and baroreceptor control of sympathetic nerve activity in humans. Hypertension 1994; 23: 294-301.
212. Meredith IT, Friberg P, Jennings GL. Exercise training lowers resting renal but not cardiac sympathetic activity in man. Hypertension 1991; 18: 575-82.
213. Negrao CE, Irigoyen MC, Moreira ED, et al. Effect of exercise training on RSNA, baroreflex control, and blood pressure responsiveness. Ann J Physiol 1993; 265: R365-70.
214. Bolter CP, Ledsome JR. Effect of cervical sympathetic nerve stimulation on canine carotid sinus reflex. Am J Physiol 1976; 230: 1026-30.
215. Seagard JL, Hopp FA, Kampine JP. Effect of sympathetic sensitization of baroreceptors on renal nerve activity. Am J Physiol 1987; 252: R328-35.
216. Malliani A, Pagani M,. Lombardi F. Power spectral analysis of heart rate variability and baroreflex gain. Clin Sci 1995; 89: 555-6.
217. Indolifi C, Torella D, Coppola C, et al. Physical training increases eNOS vascular expression and activity and reduces restenosis after balloon angioplasty or arterial stenting in rats. Am Heart J 2002; 91: 1190-7.
218. Beygui F, Feuvre CL, Maunoury C, et al. Detection of coronary restenosis by exercise electrocardiography thallium-201 perfusion imaging and coronary angiography in asymptomatic patients after percutaneous transluminal coronary angioplasty. Am J Cardiol 2000; 86: 35-40.
219. Garzon PP, Eisenberg MJ. Functional testing for the detection of restenosis after percutaneous transluminal coronary angioplasty: a meta-analysis. Canadian J Cardiol 2001; 17: 41-8.
220. DeMaio SJ, King SB, Lembo NJ, Roubin GS, Hearn JA, et al. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Nutr 1992; 11: 68-73.
221. Tardif JC, Côté G, Lespérance J, Bourassa M, Lambert J, Doucet S, et al. for the multivitamins and probucol study group. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med 1997; 337: 365-72.
222. Côté G, Tardif JC, Lespérance J, Lambert J, Bourassa M, Bonan R, et al. Effects of probucol on vascular remodeling after coronary angioplasty. Circulation 1999; 99: 30-5.
223. Serruys PW, Foley DP, Hofling B, Puel J, Glogar HD, Seabra-Gomes R, et al. Carvedilol for prevention of restenosis after directional coronary atherectomy: final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. Circulation 2000; 101: 1512-8.
224. Brehm BR, Wolf SC, Bertsch D, Klaussner M, Wesselborg S, Schuler S, et al. Effects of nebivolol on proliferation and apoptosis of human coronary artery smooth muscle and endothelial cells. Cardiovasc Res 2001; 49: 430-9. | zh_TW |